Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Handong Wang
Observed name:
Wang, Han-Dong
Institutions:
Nanjing General Hospital of Nanjing Military Command,
State Key Laboratory of Digital Medical Engineering,
Second Affiliated Hospital of Nantong University,
Southeast University
Observed institutions:
Nanjing General Hospital of Nanjing Military Command,
State Key Laboratory of Digital Medical Engineering,
Second Affiliated Hospital of Nantong University,
Southeast University
ORCID:
0000-0002-5215-2458
Observed ORCID:
0000-0002-5215-2458
OpenAlex ID:
A5109536222
RETRACTED ARTICLE: Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway
2022
·
Peng Xu
, Handong Wang
, et al.
·
Cancer Chemotherapy and Pharmacology
·
34
PDF
Ultra-fast and scalable high-resolution full-length single-cell RNA sequencing using CHART-seq
2026
·
Wenyi Zhang
, Aiqun Chen
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Decomap-seq enables efficient and reliable retrieval of spatial transcripts
2026
·
Kaiqiang Ye
, Handong Wang
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Unbiased Single-Cell Transcriptome-Proteome Co-Profiling Reveals Malignant Dormancy and Post-Transcriptional Buffering of CTCs
2026
·
Liyong He
, Kaiqiang Ye
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Retraction Note: Anlotinib combined with temozolomide suppresses glioblastoma growth via mediation of JAK2/STAT3 signaling pathway
2026
·
Peng Xu
, Handong Wang
, et al.
·
Cancer Chemotherapy and Pharmacology
PDF
Single circulating tumor cell omics: Technologies and clinical applications
2026
·
Wenyi Zhang
, Liyong He
, et al.
·
The Innovation Medicine
PDF
Show more works
View as search
Works count:
7
Citation count:
34
H-index:
1
I10-index:
1
Year
Topic
Type